
Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO
2026-11-01 10:10:05Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Eiko Lifesciences Ltd is Rated Sell
2026-10-21 10:10:02Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Eiko Lifesciences Ltd is Rated Sell
2026-10-10 10:10:05Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Eiko Lifesciences Ltd is Rated Sell
2026-09-29 10:10:03Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO
2026-09-17 10:10:04Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with the most recent insights into the company’s performance and outlook.
Read More
Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 43 as Sell-Off Deepens
2026-09-15 13:35:40For the fourth consecutive session, Eiko Lifesciences Ltd has closed lower, culminating in a fresh 52-week low of Rs 43 on 15 Sep 2026. This marks a 33.3% decline from its 52-week high of Rs 64.44, underscoring sustained selling pressure despite some positive financial signals.
Read More
Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO
2026-09-04 10:10:27Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Restructuring
13-Nov-2026 | Source : BSEIn continuation to our earlier announcement dated 05th November 2026. We wish to inform that the Wholly Owned Subsidiary of the Company namely Eiko Scientific Solutions LLP (LLPIN: ACH-4311) has entered into a Joint Venture by forming a Private Limited Company in the name of Oval Eiko Resources Private Limited.
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSEPlease find enclosed a copy of newspaper publication in the following newspapers dated 06th November 2026 with respect to Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Half-year ended 30th September 2026 approved at the meeting of Board of Directors held on Thursday 05th November 2026.
Announcement under Regulation 30 (LODR)-Restructuring
05-Nov-2026 | Source : BSEWholly Owned Subsidiary of the Company namely Eiko Scientific Solutions LLP (LLPIN: ACH-4311) is proposed to enter into a Joint Venture Agreement with Oval Projects Engineering Limited for formation of a new Private Limited Company in the name of Oval Eiko Resources Private Limited.
Corporate Actions
No Upcoming Board Meetings
Eiko Lifesciences Ltd has declared 2% dividend, ex-date: 20 Sep 17
No Splits history available
No Bonus history available
Eiko Lifesciences Ltd has announced 2:3 rights issue, ex-date: 07 Jul 23